Background Misconceptions about ADHD stigmatize affected people, reduce credibility of
providers, and prevent/delay treatment. To challenge misconceptions, we curated findings …

Pharmacologic Treatment of ADHD Amphetamines and methylphenidate and, less often,
nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD …

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental psychiatric
disorder characterized by deficits in attention and hyperactivity-impulsivity. These symptoms …

Despite a growing literature on the complex bidirectional relationship of ADHD and
substance use, reviews specifically focusing on alcohol are scarce. ADHD and AUD show a …

Background: Despite evidence-based national guidelines for ADHD in the United Kingdom
(UK), ADHD is under-identified, under-diagnosed, and under-treated. Many seeking help for …

Background To assess whether age of onset and duration of stimulant therapy for attention‐
deficit/hyperactivity disorder (ADHD) are associated with cocaine, methamphetamine, and …

Attention-deficit/hyperactivity disorder (ADHD) is a heterogeneous disorder with a high
degree of psychiatric and physical comorbidity, which complicates its diagnosis in childhood …

Background Stimulant medications are commonly prescribed for the treatment of attention-
deficit/hyperactivity disorder; however, they also have high potential for diversion and …

Evidence of sensitization following stimulants administration in humans is just emerging,
which prevents reaching more definitive conclusions in favor or against a purported …

Abstract Attention-Deficit Hyperactivity Disorder (ADHD) is a prevalent neurodevelopmental
condition associated with impaired function and increased risk of poor outcomes in children …